Micron Biomedical

News & Press Releases

In The News

BBC Spotlights “Extremely Promising” Micron Biomedical Data Publication in The Lancent

May 1, 2024

The Telegraph Spotlights Micron Biomedical Data Publication in The Lancent

May 1, 2024

Newsweek Spotlights Micron Technology as Part of Bill Gates’Plan to Change Vaccines

January 18, 2024

World Economic Forum Spotlights Micron’s Dissolvable Microneedles and the Opportunity to Increase Vaccine Uptake

November 23, 2023

Reuters Spotlights Micron’s Progress Toward Mass Production of Its Proprietary Microarray Technology

November 16, 2023

FiercePharma Spotlights Micron Biomedical’s Progress to Commercializing a Life-Saving “Button”

November 16, 2023

Press Releases

Micron Biomedical Expands World-Renowned Advisory Team with Appointment of Medtech Innovation Leader, Sandeep Patel, PhD Ahead of Commercial Manufacturing of Its Needle-Free Technology

September 5, 2024

Micron Biomedical Announces The Lancet Publication of Positive Phase 1/2 Data From First Clinical Trial of Needle-Free Vaccines in Children

May 1, 2024

Micron Biomedical Appoints Global Health Pioneer and Champion of Vaccine Access, Dr. Seth Berkley, as Scientific Advisor to the CEO

February 27, 2024

Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles

November 16, 2023

Micron Biomedical Appoints Brian Bernick, MD as Chairman of Its Board of Directors

August 9, 2023

Micron Biomedical Announces Positive Measles and Rubella Vaccination Results from First Clinical Trial of Microarray Injection-Free Vaccine Delivery in Children

May 17, 2023